Dow Down 0.32% Nasdaq Down 0.62%

More On ACR.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Acrux Limited (ACR.AX)

-ASX
0.63 Up 0.01(1.63%) 2:10AM EDT
Prev Close:0.62
Open:0.62
Bid:0.63
Ask:0.64
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.61 - 0.64
52wk Range:0.56 - 1.02
Volume:346,789
Avg Vol (3m):287,157
Market Cap:104.08M
P/E (ttm):7.18
EPS (ttm):0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):7.81
P/S (ttm):3.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :0.08
Quarterly EPS Est (Jun-16) :N/A
Mean Recommendation*:3.7
PEG Ratio (5 yr expected):-0.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acrux Limited develops and commercializes healthcare products in Australia, Switzerland, the United States, and internationally. It markets Axiron for the treatment of testosterone deficiency in men; Evamist for menopausal symptoms; and Recuvyra t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback